QA: Marker Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001094038_2023_Marker_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001094038, Marker Therapeutics Inc.

  xvar xval
0 AssetsCurrent 16,619,255
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 17,802,929
4 LiabilitiesCurrent 7,781,809
5 LiabilitiesNoncurrent 7,039,338
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,820,004
9 ResearchAndDevelopmentExpense 26,139,323
10 remainder_Expenses 0
11 remainder_Revenues 9,013,544
12 remainder_NetIncome 15,089
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 34,422,184
1 Liabilities 14,821,147
2 Expenses 38,959,327
3 Revenues 9,013,544
4 StockholdersEquity 19,601,037
5 NetIncome -29,930,694
6 ComprehensiveNetIncome -29,930,694
7 BaseVar 48,615,646
8 EconomicCapitalRatio 0.154

Edgar->Model Mapping

Feature Distribution

Change over Time